Gyre Therapeutics
GYRE
#6203
Rank
S$0.85 B
Marketcap
$9.09
Share price
-0.29%
Change (1 day)
-60.69%
Change (1 year)

P/S ratio for Gyre Therapeutics (GYRE)

P/S ratio as of April 2025 (TTM): 6.02

According to Gyre Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.47. At the end of 2024 the company had a P/S ratio of 10.1.

P/S ratio history for Gyre Therapeutics from 2024 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202410.1